Shufei Wei

Hebei, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

HOXA13 promotes prostate cancer metastasis by inhibiting ferroptosis via upregulating SLC7A11 and SLC3A2.

HOXA13 promotes prostate cancer metastasis by inhibiting ferroptosis via upregulating SLC7A11 and SLC3A2.

Journal: Cellular signalling

Published: June 25, 2025

HOXD13 knockdown attenuates apoptosis in prostate cancer via the upregulation of MDM2/p53 signaling.

HOXD13 knockdown attenuates apoptosis in prostate cancer via the upregulation of MDM2/p53 signaling.

Journal: Cell division

Published: January 13, 2025

LncRNA DRAIC facilitates the progression of renal cell carcinoma by modulting the microRNA-145-3p/ABRACL pathway signaling.

LncRNA DRAIC facilitates the progression of renal cell carcinoma by modulting the microRNA-145-3p/ABRACL pathway signaling.

Journal: Scientific reports

Published: July 04, 2024

Effect and Mechanisms of Huangqi-Shanzhuyu in the Treatment of Diabetic Nephropathy based on Network Pharmacology and In Vitro Experiments.

Effect and Mechanisms of Huangqi-Shanzhuyu in the Treatment of Diabetic Nephropathy based on Network Pharmacology and In Vitro Experiments.

Journal: Combinatorial chemistry & high throughput screening

Published: February 13, 2023

RUNX2 Mediates Renal Cell Carcinoma Invasion through Calpain2.

RUNX2 Mediates Renal Cell Carcinoma Invasion through Calpain2.

Journal: Biological & pharmaceutical bulletin

Published: November 03, 2022

KLHL21/CYLD signaling confers aggressiveness in bladder cancer through inactivating NF-κB signaling.

KLHL21/CYLD signaling confers aggressiveness in bladder cancer through inactivating NF-κB signaling.

Journal: International immunopharmacology

Published: May 10, 2022

KIF11: A potential prognostic biomarker for predicting bone metastasis-free survival of prostate cancer.

KIF11: A potential prognostic biomarker for predicting bone metastasis-free survival of prostate cancer.

Journal: Oncology letters

Published: April 22, 2022

Long Noncoding RNA MMP2-AS1 Contributes to Progression of Renal Cell Carcinoma by Modulating miR-34c-5p/MMP2 Axis.

Long Noncoding RNA MMP2-AS1 Contributes to Progression of Renal Cell Carcinoma by Modulating miR-34c-5p/MMP2 Axis.

Journal: Journal of oncology

Published: February 02, 2022

KLK4 Silencing Inhibits the Growth of Chromophobe Renal Cell Carcinoma through ERK/AKT Signaling Pathway.

KLK4 Silencing Inhibits the Growth of Chromophobe Renal Cell Carcinoma through ERK/AKT Signaling Pathway.

Journal: Kidney & blood pressure research

Published: November 19, 2021

Clinical analysis of everolimus in the treatment of metastatic renal cell carcinoma.

Clinical analysis of everolimus in the treatment of metastatic renal cell carcinoma.

Journal: Annals of palliative medicine

Published: November 24, 2020

Knockdown of PLOD3 suppresses the malignant progression of renal cell carcinoma via reducing TWIST1 expression.

Knockdown of PLOD3 suppresses the malignant progression of renal cell carcinoma via reducing TWIST1 expression.

Journal: Molecular and cellular probes

Published: March 04, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026